Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg (if DBP criteria alone is met, SBP must be ≥130 mmHg) at screening (Visit 1).
Has SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg (if DBP criteria alone is met, SBP must be ≥130 mmHg) at week 0 (Visit 3).
Untreated for hypertension, or on stable antihypertensive medications ≥ 30 days prior to Visit 1.
Have a body mass index (BMI) ≥ 25 kg/m².
You may not be if
Has SBP ≥170 mmHg and/or DBP ≥110 mmHg at Visit 1 or at Visit 3.
Has known secondary causes of hypertension
Have heart failure with reduced ejection fraction (HFrEF) diagnosis
Have had any of the following conditions within 90 days prior to screening.
* hospitalization for hypertension or for congestive heart failure
* acute coronary syndrome or acute myocardial infarction, or
* cerebrovascular accident (stroke).
Have type 1 diabetes (T1D)
Have acute or chronic hepatitis, including a history of autoimmune hepatitis
Clareo Health | A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
